Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2021-09-29 00:00:00 ET · period of report 2021-09-27 · accession 0001567619-21-017624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-29 | 2021-09-27+ | FDMT | SCHAFFER DAVID | Dir | S - Sale | $31.90 | -33.2K | 980.7K | -3% | -$1.06M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-27 | S | D | 13,075 | $32.59 | 986,925 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F3) Since the date of the reporting person's last ownership report, he transferred 1,000,000 shares of FDMT common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. |
| 2 | Common | Common Stock | 2021-09-27 | S | D | 6,157 | $33.51 | 980,768 | D | — | — | (F4) The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-09-28 | S | D | 100 | $32.00 | 966,756 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-28 | S | D | 13,812 | $30.52 | 966,856 | D | — | — | (F5) The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-09-27 | S | D | 100 | $34.19 | 980,668 | D | — | — |